Therapeutic Effects of Herbal Medicines in Different Types of Retinopathies: A Systematic Review

Overview

Journal Avicenna J Phytomed

Publisher Mashhad University of Medical Sciences

Date 2023 Jun 19

PMID 37333471

Authors

Negin Ansari-Mohseni

Adel Ghorani-Azam

Seyed Ahmad Mohajeri

Affiliations

Soon will be listed here.

Abstract

Objective: Retinopathy is an ocular manifestation of systemic diseases such as diabetes and vascular diseases. Herbal drugs have been considered as an effective therapeutic option with minimal side effects for the treatment of retinopathy by reducing the symptoms and improving visual acuity. The purpose of this systematic review was to collect studies on the effectiveness of medicinal plants in the treatment or prevention of retinopathy.

Materials And Methods: A systematic literature search was performed in PubMed, Scopus, Google Scholar, and other databases in April 2021 using "herbal products" and "Retinopathy" with all their equivalent and similar terms. For this purpose, human clinical trials with the English language were included and articles with subject irrelevancy were excluded from further evaluation.

Results: Overall, 30 articles with 2324 patients were studied for possible effects of herbal therapy on retinopathy. From 30 included articles, different herbal products had been evaluated. Out of 30 selected articles, 11 articles were for the treatment of age-related macular degeneration (AMD), 14 articles covered patients with diabetic retinopathy, and the other five studies were for other retinal disorders. The outcomes in majority of the studies include changes in visual acuity (VA), fundus performance, best-corrected visual acuity (BCVA), central macular thickness (CMT), focal electroretinogram (fERG), supplements and adjuvant medications appeared to be more beneficial in patients with AMD and diabetic maculopathy.

Conclusion: Herbal therapy can be considered as a potential candidate in the adjuvant and complementary therapies of retinopathy. However, further studies are required to verify such efficiency.

Citing Articles

Combination of (), ( L.) and Protects ARPE-19 Cells from Oxidative Stress.

Puddu A, Nicolo M, Maggi D Int J Mol Sci. 2025; 26(4).

PMID: 40003961 PMC: 11855758. DOI: 10.3390/ijms26041496.

Natural remedies proposed for the management of diabetic retinopathy (DR): diabetic complications.

Khidr E, Morad N, Hatem S, El-Dessouki A, Mohamed A, El-Shiekh R Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39954069 DOI: 10.1007/s00210-025-03866-w.

The hematopoietic potential of methanolic and aqueous extracts of in a phenylhydrazine model of anemia.

Shirani K, Riahi-Zanjani B, Omidkhoda S, Barangi S, Karimi G Avicenna J Phytomed. 2023; 13(1):85-96.

PMID: 36698739 PMC: 9840774. DOI: 10.22038/AJP.2022.20965.

References

Chous A, Richer S, Gerson J, Kowluru R . The Diabetes Visual Function Supplement Study (DiVFuSS). Br J Ophthalmol. 2015; 100(2):227-34. PMC: 4752618. DOI: 10.1136/bjophthalmol-2014-306534. View

Akkawi M, Shehadeh M, Shams A, Al-Hardan D, Omar L, Almahmoud O . Incidence and risk factors of retinopathy of prematurity in three neonatal intensive care units in Palestine. BMC Ophthalmol. 2019; 19(1):189. PMC: 6701108. DOI: 10.1186/s12886-019-1180-4. View

Luo D, Deng T, Yuan W, Deng H, Meng H, Jin M . Effects of Huangban Bianxing One decoction combined with ranibizumab on treating exudative age-related macular degeneration. J Tradit Chin Med. 2020; 39(6):892-901. View

Kumar S, Mittal A, Babu D, Mittal A . Herbal Medicines for Diabetes Management and its Secondary Complications. Curr Diabetes Rev. 2020; 17(4):437-456. DOI: 10.2174/1573399816666201103143225. View

Mazzolani F, Togni S, Giacomelli L, Eggenhoffner R, Franceschi F . Oral administration of a curcumin-phospholipid formulation (Meriva®) for treatment of chronic diabetic macular edema: a pilot study. Eur Rev Med Pharmacol Sci. 2018; 22(11):3617-3625. DOI: 10.26355/eurrev_201806_15189. View

Evans J . Ginkgo biloba extract for age-related macular degeneration. Cochrane Database Syst Rev. 2000; (2):CD001775. DOI: 10.1002/14651858.CD001775. View

Tsang S, Sharma T . Stargardt Disease. Adv Exp Med Biol. 2018; 1085:139-151. DOI: 10.1007/978-3-319-95046-4_27. View

Breithaupt D, Weller P, Wolters M, Hahn A . Comparison of plasma responses in human subjects after the ingestion of 3R,3R'-zeaxanthin dipalmitate from wolfberry (Lycium barbarum) and non-esterified 3R,3R'-zeaxanthin using chiral high-performance liquid chromatography. Br J Nutr. 2004; 91(5):707-13. DOI: 10.1079/BJN20041105. View

Chan H, Lam H, Choi K, Li S, Lakshmanan Y, Yu W . Delay of cone degeneration in retinitis pigmentosa using a 12-month treatment with Lycium barbarum supplement. J Ethnopharmacol. 2019; 236:336-344. DOI: 10.1016/j.jep.2019.03.023. View

10.

Park Y, Roh Y . New Diagnostic and Therapeutic Approaches for Preventing the Progression of Diabetic Retinopathy. J Diabetes Res. 2016; 2016:1753584. PMC: 4736008. DOI: 10.1155/2016/1753584. View

11.

Moon S, Shin Y, Cho H, Bae S, Kim H . Effect of grape seed proanthocyanidin extract on hard exudates in patients with non-proliferative diabetic retinopathy. Medicine (Baltimore). 2019; 98(21):e15515. PMC: 6571433. DOI: 10.1097/MD.0000000000015515. View

12.

Cheng C, Chung W, Szeto Y, Benzie I . Fasting plasma zeaxanthin response to Fructus barbarum L. (wolfberry; Kei Tze) in a food-based human supplementation trial. Br J Nutr. 2005; 93(1):123-30. DOI: 10.1079/bjn20041284. View

13.

Jin M, Dai H, Zhang X, Wang Y, Han M, Zhang H . A Traditional Chinese Patent Medicine ZQMT for Neovascular Age- Related Macular Degeneration: A Multicenter Randomized Clinical Trial. Curr Mol Med. 2019; 18(9):622-629. DOI: 10.2174/1566524019666190107155311. View

14.

Karimi A, Majlesi M, Rafieian-Kopaei M . Herbal versus synthetic drugs; beliefs and facts. J Nephropharmacol. 2017; 4(1):27-30. PMC: 5297475. View

15.

Petri A, Boysen K, Cehofski L, van Dijk E, Dysli C, Fuchs J . Intravitreal Injections with Vascular Endothelial Growth Factor Inhibitors: A Practical Approach. Ophthalmol Ther. 2020; 9(1):191-203. PMC: 7054499. DOI: 10.1007/s40123-020-00230-4. View

16.

Luo D, Qin Y, Yuan W, Deng H, Zhang Y, Jin M . Compound Danshen Dripping Pill for Treating Early Diabetic Retinopathy: A Randomized, Double-Dummy, Double-Blind Study. Evid Based Complement Alternat Med. 2015; 2015:539185. PMC: 4592726. DOI: 10.1155/2015/539185. View

17.

Steigerwalt R, Belcaro G, Cesarone M, Di Renzo A, Grossi M, Ricci A . Pycnogenol improves microcirculation, retinal edema, and visual acuity in early diabetic retinopathy. J Ocul Pharmacol Ther. 2009; 25(6):537-40. DOI: 10.1089/jop.2009.0023. View

18.

Fernandez-Albarral J, de Hoz R, Ramirez A, Lopez-Cuenca I, Salobrar-Garcia E, Pinazo-Duran M . Beneficial effects of saffron ( L.) in ocular pathologies, particularly neurodegenerative retinal diseases. Neural Regen Res. 2020; 15(8):1408-1416. PMC: 7059587. DOI: 10.4103/1673-5374.274325. View

19.

Penn J, Madan A, Caldwell R, Bartoli M, Caldwell R, Hartnett M . Vascular endothelial growth factor in eye disease. Prog Retin Eye Res. 2008; 27(4):331-71. PMC: 3682685. DOI: 10.1016/j.preteyeres.2008.05.001. View

20.

Benzie I, Chung W, Wang J, Richelle M, Bucheli P . Enhanced bioavailability of zeaxanthin in a milk-based formulation of wolfberry (Gou Qi Zi; Fructus barbarum L.). Br J Nutr. 2006; 96(1):154-60. DOI: 10.1079/bjn20061796. View